Sotera Health Acquires Canadian-based Iotron Industries

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

Canadian-based Iotron Industries has been acquired by Sotera Health, the world’s leading, fully-integrated protector of global health. The news was announced today (August 3, 2020).

The acquisition expands the company’s electron beam (EBeam) footprint and adds new expertise to its Sterigenics business. Iotron Industries is a leading outsourced provider of EBeam sterilization in North America.

With facilities in Columbia City (Indiana), Port Coquitlam (British Columbia), and Edmonton (Alberta), Iotron Industries has an outstanding reputation for customer service, technical expertise and quality performance. Iotron is well regarded for its proprietary IMPELA® accelerators, which provide high powered EBeam processing for the sterilization of medical devices and a wide range of industrial applications.

“Iotron Industries is a well-respected provider of electron beam sterilization known for its strong customer relationships and the expertise of its employees,” said Michael B. Petras Jr., CEO of Sotera Health. “While this acquisition expands our overall sterilization footprint, it also enhances our EBeam capabilities and the strength of our offering to the market. We welcome Iotron’s management and strong team as they join our mission of Safeguarding Global Health®.”

“I am exceedingly proud of the thriving business and expert team that we have built together at Iotron, and we all look forward to accelerating our growth as part of a global leader,” said Tino Pereira, President and CEO of Iotron Industries. “Iotron and Sotera Health share common values around safety, customer focus, integrity, people and a commitment to excellence. We look forward to a brighter future together.”

The addition of Iotron will complement Sotera Health’s Sterigenics business and enhance Sterigenics’ existing global, technology-agnostic sterilization platform.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles